Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease

NCT00010387 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT00010387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00010387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
March 31, 1999
Completion date
Not reported
Enrollment
32
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, hemolytic, autoimmune, autoimmune diseases, felty syndrome, purpura, thrombocytopenic